Suppr超能文献

下肢缺血局部动脉内溶栓治疗出血的危险因素。

Risk factors for haemorrhage during local intra-arterial thrombolysis for lower limb ischaemia.

机构信息

Vascular Center, Malmö University Hospital, 20502 Malmö, Sweden.

出版信息

J Thromb Thrombolysis. 2011 Feb;31(2):226-32. doi: 10.1007/s11239-010-0520-2.

Abstract

Assessment of clinical risk factors for haemorrhagic complications in patients undergoing intra-arterial thrombolysis for lower limb ischaemia. Retrospective reviews of consecutive patients subjected to intra-arterial thrombolysis due to lower limb ischemia at the Vascular Center, Malmö University Hospital, during a 5-year period from 2001 to 2005. Two hundred and twenty intra-arterial thrombolytic procedures were carried out in 195 patients (46% women), median age 73 years. Haemorrhagic complications were recorded in 72 procedures (33%), of which 13 were discontinued. Haemorrhage at the introducer and distant sites occurred in 53 and 32 procedures, respectively. Thrombolysis for occluded synthetic grafts was associated with higher risk of haemorrhage (P = 0.043). The platelet count was lower (P = 0.017) and the dose of alteplas higher (P = 0.041) in bleeders than in non-bleeders. Age was not associated with haemorrhage (P = 0.30). Two patients died during thrombolysis, one of them due to intracerebral haemorrhage. The grade of thrombolysis was an independent predictor of both in-hospital amputation (P < 0.001; OR 3.5 [95% CI 2.1-5.8]) and mortality (P = 0.021; OR 3.0 [95% CI 1.2-7.9]). The in-hospital amputation-free survival rate was 85% (188/220). Haemorrhage associated with thrombolysis is common, but does seldom require discontinuation of treatment. Insertion of introducers for local thrombolysis through synthetic grafts, lower platelet count and higher alteplas dose were found to be risk factors for haemorrhage. An algorithm for clinical management of haemorrhage has been proposed.

摘要

评估下肢缺血患者行动脉内溶栓治疗的出血并发症的临床危险因素。对 2001 年至 2005 年期间在马尔默大学医院血管中心因下肢缺血接受动脉内溶栓治疗的连续患者进行回顾性分析。195 例患者(46%为女性)共行 220 次动脉内溶栓治疗,中位年龄 73 岁。72 次(33%)出现出血并发症,其中 13 次停止治疗。分别有 53 次和 32 次出现导丝入口和远处部位出血。闭塞的合成移植物溶栓与更高的出血风险相关(P = 0.043)。出血患者的血小板计数较低(P = 0.017),alteplas 剂量较高(P = 0.041)。年龄与出血无关(P = 0.30)。2 例患者在溶栓过程中死亡,其中 1 例死于脑出血。溶栓后的分级是住院截肢(P < 0.001;OR 3.5 [95% CI 2.1-5.8])和死亡率(P = 0.021;OR 3.0 [95% CI 1.2-7.9])的独立预测因子。住院无截肢生存率为 85%(188/220)。溶栓相关出血较为常见,但很少需要停止治疗。经合成移植物插入局部溶栓导丝、血小板计数较低和 alteplas 剂量较高被认为是出血的危险因素。已经提出了一种用于出血临床管理的算法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验